Determining Ethyl Glucuronide Cutoffs When Detecting Self-Reported Alcohol Use In Addiction Treatment Patients

BACKGROUND: Ethyl glucuronide (EtG) is an alcohol biomarker with potential utility as a clinical research and alcohol treatment outcome. Debate exists regarding the appropriate cutoff level for determining alcohol use, particularly with the EtG immunoassay. This study determined the EtG immunoassay...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Alcohol Clin Exp Res
Prif Awduron: Lowe, Jessica M., McDonell, Michael G., Leickly, Emily, Angelo, Frank A., Vilardaga, Roger, McPherson, Sterling, Srebnik, Debra, Roll, John, Ries, Richard K.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4400217/
https://ncbi.nlm.nih.gov/pubmed/25866234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.12699
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg